AZN vs. OPRA
AZN (AstraZeneca PLC) and OPRA (Opera Limited) are both stocks. AZN operates in Drug Manufacturers - General (Healthcare), while OPRA operates in Internet Content & Information (Communication Services). Over the past 5 years, AZN returned 10.93%/yr vs 20.73%/yr for OPRA. Their 0.09 correlation means their historical movements had little consistent relationship.
Performance
AZN vs. OPRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AZN achieves a -4.86% return, which is significantly lower than OPRA's 38.24% return.
AZN
- 1D
- -1.13%
- 1M
- -9.64%
- 6M
- -5.54%
- YTD
- -4.86%
- 1Y
- 14.99%
- 3Y*
- 8.61%
- 5Y*
- 10.93%
- 10Y*
- 13.01%
- ALL TIME*
- 12.67%
OPRA
- 1D
- -0.43%
- 1M
- -3.98%
- 6M
- 41.25%
- YTD
- 38.24%
- 1Y
- 21.96%
- 3Y*
- 6.39%
- 5Y*
- 20.73%
- 10Y*
- —
- ALL TIME*
- 7.07%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $437.01M | $502.71M | $405.86M | |
OPRA Opera Limited | $6.41M | $6.73M | $6.74M |
AZN vs. OPRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | -4.86% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 0.71% |
OPRA Opera Limited | 38.24% | -22.08% | 52.02% | 140.60% | -10.91% | -22.67% | -1.30% | 66.37% | -61.23% |
Correlation
The correlation between AZN and OPRA is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.04 |
Correlation (3Y) Balances recent behavior with more history. | 0.08 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jul 27, 2018 | 0.09 |
Fundamentals
AZN:
$132.79B
OPRA:
$1.67B
AZN:
$13.34
OPRA:
$1.26
AZN:
12.84
OPRA:
14.81
AZN:
0.02
OPRA:
0.06
AZN:
2.19
OPRA:
2.62
AZN:
2.66
OPRA:
1.72
AZN:
$61.18B
OPRA:
$647.66M
AZN:
$48.56B
OPRA:
$378.92M
AZN:
$20.49B
OPRA:
$154.47M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AZN vs. OPRA — Risk / Return Rank
AZN
OPRA
AZN vs. OPRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Opera Limited (OPRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AZN | OPRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.13 | ||
| Sortino ratioReturn per unit of downside risk | -0.05 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.12 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 0.72 | 0.53 | +0.18 |
| Martin ratioReturn relative to average drawdown | 1.91 | 0.97 | +0.94 |
Loading charts...
Drawdowns
AZN vs. OPRA - Drawdown Comparison
The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum OPRA drawdown of -72.85%. Use the drawdown chart below to compare losses from any high point for AZN and OPRA.
Loading charts...
Drawdown Indicators
| AZN | OPRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.94% | -72.85% | +23.91% |
Max Drawdown (1Y)Largest decline over 1 year | -21.08% | -41.28% | +20.20% |
Max Drawdown (3Y)Largest decline over 3 years | -27.87% | -43.39% | +15.52% |
Max Drawdown (5Y)Largest decline over 5 years | -27.87% | -61.86% | +33.99% |
Max Drawdown (10Y)Largest decline over 10 years | -27.87% | — | — |
Current DrawdownCurrent decline from peak | -17.80% | -22.15% | +4.35% |
Average DrawdownAverage peak-to-trough decline | -11.38% | -40.76% | +29.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.91% | 22.64% | -14.73% |
Volatility
AZN vs. OPRA - Volatility Comparison
AstraZeneca PLC (AZN) and Opera Limited (OPRA) have volatilities of 12.13% and 12.04%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AZN | OPRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.13% | 12.04% | +0.09% |
Volatility (6M)Calculated over the trailing 6-month period | 20.07% | 39.77% | -19.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.44% | 52.42% | -24.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.51% | 60.61% | -36.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.95% | 64.01% | -39.06% |
Dividends
AZN vs. OPRA - Dividend Comparison
AZN's dividend yield for the trailing twelve months is around 3.11%, less than OPRA's 4.28% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 3.11% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
OPRA Opera Limited | 4.28% | 5.65% | 4.22% | 8.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
AZN vs. OPRA - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and Opera Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AZN vs. OPRA - Profitability Comparison
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, AstraZeneca PLC reported a gross profit of 11.18B and revenue of 15.19B. Therefore, the gross margin over that period was 73.6%.
OPRA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Opera Limited reported a gross profit of 111.02M and revenue of 175.77M. Therefore, the gross margin over that period was 63.2%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, AstraZeneca PLC reported an operating income of 3.07B and revenue of 15.19B, resulting in an operating margin of 20.2%.
OPRA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Opera Limited reported an operating income of 30.43M and revenue of 175.77M, resulting in an operating margin of 17.3%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, AstraZeneca PLC reported a net income of 2.48B and revenue of 15.19B, resulting in a net margin of 16.3%.
OPRA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Opera Limited reported a net income of 24.79M and revenue of 175.77M, resulting in a net margin of 14.1%.
Frequently Asked Questions
AZN and OPRA have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AZN has higher volatility (12.13%) compared to OPRA (12.04%). In terms of maximum drawdown, AZN dropped -48.94% vs OPRA's -72.85%.
AZN currently has the higher Sharpe Ratio (0.56 vs 0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AZN and OPRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer